
Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy
Introduction Psoriasis is a chronic inflammatory skin disease affecting between 2% and 3% of the global population.1,2 Psoriasis is now recognized as a systemic condition.3 Up to 30% of patients will develop psoriatic arthritis, and approximately 1% are …